Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > 2 things

<< Previous

Bullboard Posts

Next >>

Comment by patience69on Jan 28, 2024 6:12pm

222 Views

Post# 35849627

RE:RE:RE:RE:2 things

Camp & Enrique. I could not agree with you guys more. Why is Merck for one doing trials with everybody to try to extend the patent life of keytruda & we just sit there out of cash? Obviously they have a ton to lose. Is it because we are a drug & a device? Is it because they dont perceive us as a threat? What the heck are they waiting for???

<< Previous

Bullboard Posts

Next >>

NervGen Pharma: Proof that NVG-291 works?